文献速递浆细胞疾病

不同种族多发性骨髓瘤患者中糖尿病的患病率及其对生存的影响

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
PubMed 文献 · Blood Adv · 2024-01-01

该回顾性临床研究纳入5383例多发性骨髓瘤患者,其中15%合并糖尿病(白人12%、黑人25%)。多变量Cox模型显示合并糖尿病者总生存期缩短(HR 1.27,95%CI 1.11-1.47,P<.001),这一关联似由白人患者驱动而非黑人患者;肥胖在黑人患者中与更好总生存相关。小鼠模型显示骨髓瘤移植瘤在Rag1-/-/MKR小鼠中生长更快且S6核糖体蛋白磷酸化水平更高。

要点

  • 多发性骨髓瘤患者中糖尿病患病率为15%(白人12%、黑人25%)。
  • 合并糖尿病患者总生存期缩短(HR 1.27,95%CI 1.11-1.47,P<.001),主要见于白人而非黑人。
  • 黑人患者中肥胖与更好总生存相关,白人患者中未见此关联。

核心结论

  • 糖尿病可能促进黑人个体多发性骨髓瘤的较高发病率,且为改善多发性骨髓瘤生存,糖尿病管理不可忽视。

研究设计与样本

  • 回顾性临床研究纳入5383例多发性骨髓瘤患者,其中15%合并糖尿病(白人12%、黑人25%)。
  • 采用基因工程免疫缺陷非肥胖糖尿病小鼠模型(Rag1-/-/MKR)评估糖尿病与多发性骨髓瘤的机制联系。

主要发现

  • 多变量Cox模型显示合并糖尿病患者总生存期缩短(HR 1.27,95%CI 1.11-1.47,P<.001)。
  • 总生存期差异似由白人患者中合并与不合并糖尿病的显著差异驱动,黑人患者中未见此差异。
  • 肥胖在黑人患者中与更好总生存相关,在白人患者中未见此关联。
  • MM.1S移植瘤在更多Rag1-/-/MKR小鼠中生长,且较对照生长更快。
  • Rag1-/-/MKR小鼠来源的MM1.S移植瘤磷酸化S6核糖体蛋白(Ser235/236)水平更高,提示哺乳动物雷帕霉素靶蛋白通路激活增强。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) is twice as common in Black individuals compared with in White individuals, and diabetes mellitus (DM) disproportionately affects Black patients. Although numerous studies have shown a correlation between DM and MM, this has not been studied in the context of race and in vivo mechanisms. We conducted a retrospective clinical study of 5383 patients with MM of which 15% had DM (White, 12% and Black, 25%). Multivariable Cox models showed reduced overall survival (OS) for patients with DM (hazard ratio, 1.27; 95% confidence interval, 1.11-1.47; P < .001). This appeared to be driven by a marked difference in OS between White patients with and without DM but not in Black patients. In contrast, obesity was associated with better OS in Black patients but not in White patients. To complement this analysis, we assessed MM growth in a genetically engineered immunocompromised nonobese diabetic (Rag1-/-/muscle creatinine kinase promoter expression of a human IGF1R [M] with a lysine [K] to arginine [R] point mutation) mouse model to evaluate the mechanisms linking DM and MM. MM.1S xenografts grew in more Rag1-/-/MKR mice and grew more rapidly in the Rag1-/-/MKR mice compared with in controls. Western blot analysis found that MM1.S xenografts from Rag1-/-/MKR mice had higher phosphorylated S6 ribosomal protein (Ser235/236) levels, indicating greater activation of the mammalian target of rapamycin pathway. Our study is, to our knowledge, the first to evaluate racial differences in DM prevalence and survival in MM, as well as the effect of DM on tumor growth in mouse models. Our results suggest that DM may contribute to the higher incidence of MM in Black patients; and to improve survival in MM, DM management cannot be ignored.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Shah UA, Moshier E, Derkach A, et al. Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups. Blood Adv. 2024. PMID: 37772981. doi:10.1182/bloodadvances.2023010815

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。